Local Business Alert: GlaxoSmithKline buys Human Genome Sciences for $3.6B

   
The Washington Post Monday, July 16, 2012 11:20:17 AM
LOCAL BUSINESS ALERT

GlaxoSmithKline buys Human Genome Sciences for $3.6B


British drugmaker GlaxoSmithKline has agreed to pay $3.6 billion for Rockville-based Human Genome Sciences after a months-long acquisition dispute over the company's true value.

Glaxo has extended multiple buyout offers since April to both the HGS board of directors and its shareholders that valued the company at $2.6 billion, or $13 per share, but the company repeatedly rejected them as too low.


Read more at:
http://www.washingtonpost.com/blogs/capital-business/post/glaxosmithkline-buys-human-genome-sciences-for-36b/2012/07/16/gJQAW9JfoW_blog.html



Or visit Capital Business or the Local Business section on washingtonpost.com.

Advertisement

SEND TO A FRIEND UNSUBSCRIBE E-MAIL CENTER GET HELP
Washington Post Digital
E-mail Customer Care
1150 15th Street NW
Washington, D.C. 20071 
©2011 The Washington Post

Privacy Policy

Post a Comment

emo-but-icon

Most Top Article

Follow Us

Hot in week

item